Functionally, these TREM2+ tumor-associated macrophages (TAMs) inhibit cytotoxic T lymphocyte (CTL) recruitment and activation, facilitate extracellular matrix (ECM) remodeling, and promote an immune-excluded tumor architecture. The gene discussed is TREM2; the disease is neoplasm.